Alpha 2.0
Login Register
» Authors » Jesper Kjaergaard

Jesper Kjaergaard

Explore the profile of Jesper Kjaergaard including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 355
Citations 4731
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Emergency Medicine
General Medicine
Top 10 Co-Authors
Christian Hassager
Niklas Nielsen
Michael Wanscher
Hans Friberg
John Bro-Jeppesen
Jacob Eifer Moller
Lars Kober
Johannes Grand
Sebastian Wiberg
Tobias Cronberg
Published In
Resuscitation
Eur Heart J Acute Cardiovasc Care
Ugeskr Laeger
Crit Care
Trials
Affiliations
Soon will be listed here.
Recent Articles
1.
Microbiological aetiology of paediatric respiratory tract infections in Kyrgyzstan
Osmonbaeva N, Bloch J, Erkinbaeva A, Tilebalieva A, Tolobekova R, Zhaparova M, et al.
BMC Infect Dis . 2025 Feb; 25(1):280. PMID: 40011805
Introduction: Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality in children worldwide. Aetiologic virus and bacteria vary geographically. To date, no systematic data on RTI aetiologies...
2.
C-reactive protein testing in primary care and antibiotic use in children with acute respiratory tract infections in Kyrgyzstan: an open-label, individually randomised, controlled trial
Isaeva E, Bloch J, Akylbekov A, Skov R, Poulsen A, Kurtzhals J, et al.
Lancet Reg Health Eur . 2025 Jan; 51:101184. PMID: 39886015
Background: Addressing the global antibacterial resistance crisis and aligning with the Kyrgyz Ministry of Health's research priorities, this study assesses the efficacy and safety of C-reactive protein (CRP) testing to...
3.
Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism
Sonne-Holm E, Kjaergaard J, Bang L, Kober L, Fosbol E, Hassager C, et al.
Thromb Res . 2025 Jan; 247:109274. PMID: 39862753
Background: In patients with pulmonary embolism (PE), the impact of repeated troponin I or T (TnI/TnT) measurements remains unclear. Methods: Using Danish national registries, we identified PE patients (≥18 years)...
4.
Mechanical circulatory support: when, how, and for whom
Moller J, Thiele H, Morrow D, Kjaergaard J, Hassager C
Eur Heart J . 2025 Jan; PMID: 39791535
Cardiogenic shock represents a critical condition in which the heart is unable to maintain adequate circulation leading to insufficient tissue perfusion and end-organ failure. Temporary mechanical circulatory support offers the...
5.
Association between hemolysis markers and neuron-specific enolase in AMICS patients supported with a microaxial flow pump
Alaoui-Ismaili Z, Klein A, Josiassen J, Helgestad O, Korsholm Jeppesen K, Ravn H, et al.
Eur Heart J Acute Cardiovasc Care . 2025 Jan; PMID: 39790017
Background: Acute myocardial infarction complicated by cardiogenic shock (AMICS) is frequently preceded by out-of-hospital cardiac arrest (OHCA), with risk of anoxic brain injury. Neuron-specific enolase (NSE) is central to neuroprognostication;...
6.
The prognostic value of neurohormonal and inflammatory biomarkers in addition to the TIMI risk score in patients with ST-elevation myocardial infarction
Duus Holle S, Soholm H, Moller J, Winther-Jensen M, Kunkel J, Jensen L, et al.
Biomarkers . 2025 Jan; 30(1):1-9. PMID: 39773138
Background: The Thrombolysis in Myocardial Infarction (TIMI) risk score estimates mortality for patients with ST-elevation myocardial infarction (STEMI). This study aimed to investigate whether biomarkers reflecting the neurohormonal response (pro-atrial...
7.
A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high risk pulmonary embolism-the STRATIFY trial: design and statistical analysis plan
Kjaergaard J, Carlsen J, Sonne-Holm E, Wiberg S, Holmvang L, Lassen J, et al.
Trials . 2024 Dec; 25(1):853. PMID: 39732696
Background: Intermediate-high risk pulmonary embolism (PE) carries a significant risk of hemodynamic deterioration or death. Treatment should balance efficacy in reducing clot burden with the risk of complications, particularly bleeding....
8.
Hemodynamic Characteristics and Prognostic Implication of Modified Society for Cardiovascular Angiography and Interventions Shock Classification in Comatose Patients With Out-of-Hospital Cardiac Arrest
Linde L, Beske R, Meyer M, Molstrom S, Grand J, Helgestad O, et al.
J Am Heart Assoc . 2024 Dec; 14(1):e036659. PMID: 39704227
Background: Cardiogenic shock complicating acute myocardial infarction is associated with a high mortality rate. Cardiogenic shock after out-of-hospital cardiac arrest (OHCA) can be due to transient myocardial stunning but also...
9.
Lower vs. higher blood pressure targets during intensive care of comatose patients resuscitated from out-of-hospital cardiac arrest-a Bayesian analysis of the BOX trial
Grand J, Granholm A, Wiberg S, Schmidt H, Moller J, Molstrom S, et al.
Eur Heart J Acute Cardiovasc Care . 2024 Dec; 14(1):14-23. PMID: 39658315
Aims: The Blood Pressure and Oxygenation (BOX) targets after out-of-hospital cardiac arrest trial found no statistically significant differences in mortality or neurological outcomes with mean arterial blood pressure targets of...
10.
Interleukin 6 blockage alters the plasma metabolome in out-of-hospital cardiac arrest
Beske R, Meyer M, Emil Roelsgaard Obling L, Moller J, Kjaergaard J, Johansson P, et al.
Resuscitation . 2024 Nov; 205():110425. PMID: 39510308
Background: Comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA) exhibit a systemic inflammatory response, as indicated by elevated interleukin-6 (IL-6) levels, which is associated with increased mortality. Tocilizumab, an IL-6...